cGxP.wire https://validator.w3.org/feed/docs/rss2.html Johnson & Johnson’s Nipocalimab Shows Strong SLE Results Eos SENOLYTIX Highlights PTC-2105 Preclinical Data at Obesity Forum Mabwell Receives NMPA Clearance for 9MW5211 in Inflammatory Bowel Disease CClimb Bio Advances CLYM116 After Encouraging Phase 1 Safety Results Amneal Reports Positive Phase 4 ELEVATE-PD Results for CREXONT Jazz Highlights New Xywav Data Across Narcolepsy and Idiopathic Hypersomnia Novo Nordisk Reports Strong Phase 2 Zenagamtide Data BioCardia Gains FDA Support for Heart Failure Therapy Zepto Receives FDA Breakthrough Designation for FungiFlex Test Biogen Highlights Kidney Disease Data at ERA and ATC 2026 Rise Therapeutics Completes Enrollment in R-2487 Rheumatoid Arthritis Trial Novo Nordisk Launches Wegovy Pill in UAE Market Elanco Expands Response to New World Screwworm Threat Teva Reports New AUSTEDO Data in Huntington’s Chorea Kashiv BioSciences Moves Closer to Launching XOLAIR Biosimilar in Canada Cycle Pharmaceuticals and Flex Pharma Advance CML Treatment with CAVHANZA Approval Alkem Launches India’s First Semaglutide Pre-Filled Syringe Regeneron Highlights Phase 3 FOP and Metabolic Data Otsuka’s VOYXACT Preserves Kidney Function in Phase 3 IgAN Trial Tenaya Reports Positive TN-201 Gene Therapy Data in MYBPC3-Associated HCM Lundbeck Reports Positive Phase IIb Migraine Trial Data NanoDetection and Oligomerix Partner to Advance Tau-Based Neurodegenerative Diagnostics Chiesi Wins EU Approval for Pediatric LOJUXTA Use Vaxcyte Doses First Participant in Phase 1 Trial of VAX-A1 for Group A Strep Prevention Pfizer Partners with Chai Discovery to Accelerate AI-Powered Drug Discovery Tenaya Therapeutics Prepares New TN-201 Gene Therapy Data for Genetic Heart Disease Agilent Expands FDA-Approved PD-L1 Testing for KEYTRUDA Across Four Cancer Types Zenas BioPharma Reports Positive Phase 3 Obexelimab Results in IgG4-RD DBV Technologies Screens First Infant in THRIVE Peanut Allergy Study AstraZeneca’s Camizestrant Extends Survival in ESR1-Mutant Breast Cancer Senzime Expands Pediatric Anesthesia Presence with New U.S. Hospital Contract Philips Gains FDA Clearance for AI Ultrasound Upgrade argenx Reports Long-Term Efgartigimod Benefits in Myositis and Sjogren’s Disease at EULAR 2026 Innovent’s IBI343 Shows Strong Efficacy in Phase III Study, Eyes Regulatory Approval CytomX and Regeneron Expand $4B Cancer Immunotherapy Alliance Lundbeck and Cradle Harness AI to Accelerate CNS Drug Discovery Australia Approves Amtagvi for Advanced Melanoma Care Alvotech Advances Key U.S. Biosimilars Toward FDA Review Philips and WellSpan Forge AI-Powered Healthcare Alliance Gilead’s Livdelzi Achieves Key Phase 3 PBC Trial Goal Alnylam and Inceptive Forge $2B AI-RNAi Discovery Alliance Oncolytics Reports Promising Pelareorep Data in RAS Cancers FDA Authorizes Signati Medical’s Multi-Center Trial for Separo System Travere Licenses Civorebrutinib in $1.14B Kidney Disease Deal Xbrane Nears FDA Decision for Lucamzi Biosimilar Alamar Launches NULISA Kit for Home-Based Proteomics Levicept’s LEVI-04 Shows Disease-Modifying Potential in Osteoarthritis Lupin and Natco Win U.S. FDA Approval for Eribulin Injection Teva Launches AHZANTIVE Biosimilar to Eylea Across Europe RedHill Advances Opaganib as Potential Ebola Treatment Amid Rare Bundibugyo Virus Outbreak